通过降低HLA编码基因的调节,LCMR1促进大细胞肺癌的扩散和转移
Lu Liu1,2, Chunsun Li3, Zhen Wu3
1Medical School of Chinese PLA, Beijing 100853, China.
Cancers
|November 25, 2023
概括
LCMR1基因驱动大细胞肺癌的生长和扩散. 抑制LCMR1可以减少瘤的进展,并可能为肺癌提供一种新的临床治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肺癌,特别是非小细胞肺癌 (NSCLC),在全球死亡率很高.
- 此前,LCMR1基因已在人类大细胞肺癌细胞系中被发现.
- 了解LCMR1的作用对于开发新的肺癌疗法至关重要.
研究的目的:
- 研究LCMR1基因在大细胞肺癌的扩散和转移中的作用.
- 探索LCMR1作为肺癌治疗点的潜力.
主要方法:
- 在LCMR1.1.的泛癌和NSCLC细胞系表达造型分析中.
- 功能性研究涉及lentivirus介导的LCMR1在癌细胞中的击倒.
- 异种移植小鼠模型来评估瘤生长抑制.
- 涉及RNA Pol II占用和人类白细胞抗原 (HLA) 基因转录的机制研究.
- 使用癌症基因组图谱 (TCGA) 数据库进行相关性分析.
主要成果:
- 在大多数固体瘤中,LCMR1的表达很高,特别是在NSCLC和95D大细胞肺癌细胞系中.
- 击败LCMR1显著抑制了培养的大细胞肺癌细胞的增殖,迁移和入侵.
- 阻断LCMR1在异种移植小鼠模型中减少了瘤生长.
- 发现LCMR1降低了HLA基因促进者的RNA Pol II占用率,抑制了它们的转录.
- 在TCGA数据中观察到LCMR1和HLA基因表达之间的负相关性.
结论:
- LCMR1对于大细胞肺癌细胞的生长和入侵至关重要.
- 通过降低HLA表达的调节,LCMR1在免疫逃避中发挥作用.
- 在大细胞肺癌的临床干预中,LCMR1是一个有前途的治疗点.
更多相关视频
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.6K
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
7.4K
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
